Strategic Development for EndoLume's NIR-II Imaging Platform

Strategic Development for Medical Innovation – EndoLume

This portfolio sample highlights my work supporting a next-generation NIR-II imaging platform designed to improve surgical outcomes for endometriosis patients. I helped shape the project’s investor and acquisition narrative, addressing both clinical and economic pain points with a streamlined package of strategic materials.

Scope of Work Included:

Defined the product’s positioning and clinical use case

Created an evidence-backed ROI model and reimbursement plan

Outlined regulatory milestones (IND, 510(k), BDD)

Synthesized clinical data into a compelling visual ladder of unmet need

Built a full acquisition-focused briefing dossier for partner review

Outcome:

The project helped the team secure high-level industry attention and opened the door to early acquisition conversations with major surgical device manufacturers.